Moderna, Aldevron extends partnership for mRNA vaccine and therapeutic pipeline
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna
Moderna, Aldevron Extends Partnership For MRNA Vac | 25/05/2021 | By Darshana | 244
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy